Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by IQT. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by IQT or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

IQT Explains: Biotech and Investments, Part 2

23:05
 
Share
 

Manage episode 454778177 series 2965877
Content provided by IQT. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by IQT or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Welcome to another episode of IQT Explains! In Part 2 of our Biotech and Investments series, we continue to explore IQT's cutting-edge work in biotechnology, focusing on our more recent investment activity and breaking down the latest developments in this ever-evolving domain. Our guests, Eugene Chiu and Dr. Michelle Rozo, delve into IQT's unique architectural approach, advancements in mRNA vaccines, gene editing, and AI-enabled biotech, as well as the challenges and opportunities ahead.

Tune in for an insightful discussion on the current biotech landscape and its impact on national security.

Key Topics

- Global Competition and U.S. Response

- Latest Developments and Innovations

- Challenges and Opportunities Ahead

- Geopolitical Influence

- Future Prospects and Potential Risks

Featured in this Episode

Farid Nemri

Program Manager

LinkedIn: https://www.linkedin.com/in/faridnemri/

Eugene Chiu

Senior Partner, Investments

LinkedIn - https://www.linkedin.com/in/eugenechiu

Dr. Michelle Rozo

VP Technology

LinkedIn - https://www.linkedin.com/in/michelle-rozo

  continue reading

83 episodes

Artwork
iconShare
 
Manage episode 454778177 series 2965877
Content provided by IQT. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by IQT or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Welcome to another episode of IQT Explains! In Part 2 of our Biotech and Investments series, we continue to explore IQT's cutting-edge work in biotechnology, focusing on our more recent investment activity and breaking down the latest developments in this ever-evolving domain. Our guests, Eugene Chiu and Dr. Michelle Rozo, delve into IQT's unique architectural approach, advancements in mRNA vaccines, gene editing, and AI-enabled biotech, as well as the challenges and opportunities ahead.

Tune in for an insightful discussion on the current biotech landscape and its impact on national security.

Key Topics

- Global Competition and U.S. Response

- Latest Developments and Innovations

- Challenges and Opportunities Ahead

- Geopolitical Influence

- Future Prospects and Potential Risks

Featured in this Episode

Farid Nemri

Program Manager

LinkedIn: https://www.linkedin.com/in/faridnemri/

Eugene Chiu

Senior Partner, Investments

LinkedIn - https://www.linkedin.com/in/eugenechiu

Dr. Michelle Rozo

VP Technology

LinkedIn - https://www.linkedin.com/in/michelle-rozo

  continue reading

83 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play